As a follow up to clinical trials presented at ATS 2024, International Conference Committee (ICC) chair and chair-elect, Drs. Debra M. Boyer and Jennifer Taylor-Cousar, moderated a webinar on the ASPEN study with Drs. James Chalmers and Doreen J. Addrizzo-Harris.
On May 28, 2024, Insmed announced positive topline results from the ASPEN Study of Brensocatib in Patients with Bronchiectasis.
Drs. Chalmers and Addrizzo-Harris presented data, answered questions and shared additional positive results from this landmark trial.
Debra M. Boyer, MD, MPHE, ATSF
Nationwide Children's Hospital
Moderator
Jennifer Taylor-Cousar, MD, MSCS, ATSF
National Jewish Health
Moderator
James Chalmers, MBChB, MD, PhD
The University of Dundee
Panelist
